ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Specialized SPARC-forming Regulatory T Cells Control Venous Blood Clot Degradation

F. Shahneh1, M. Klein2, F. Frauhammer3, H.C. Probst2, K. Schäfer4, V.K Raker5, C. Becker5

1University Medical Center Mainz, Department of Dermatology, Mainz, Germany, 2University Medical Center Mainz, Institute for Immunology, Mainz, Germany, 3University of Heidelberg (ZMBH), Center for Molecular Biology, Heidelberg, Germany, 4University Medical Center Mainz, Center for Thrombosis and Hemostasis, Mainz, Germany, 5University Hospital Münster, Department of Dermatology, Münster, Germany

Abstract Number: OC 16.3

Meeting: ISTH 2021 Congress

Theme: Vascular Biology » Innate and Adaptive Immunity

Background: Regulatory T cells (Treg) suppress pathological immune responses, maintain tissue homeostasis and potentiate tissue repair after damage. While immunoregulatory Treg activities in lymphoid tissues have been extensively studied, little is known about Treg activities in non-lymphoid tissues and venous thrombosis has not been studied so far.

Aims: Elucidation of the phenotype, function and therapeutic benefit of Treg that accumulate in venous thrombi.

Methods: Mouse vena cava ligation model including re-ligation experiments, reporter and knockout mice, selective Treg depletion or expansion in vivo, adoptive transfer experiments, flow cytometry and flow-assisted cell sorting, bulk RNA-Seq and scRNA-Seq, Histology.

Results: 1) Treg accumulate in venous blood clots and determine the rate of thrombus resolution.  
2) Clot-busting Treg control monocyte numbers and differentiation in resolving thrombi.
3) Clot Treg express a repair Treg cell profile and contain a distinct population that produces the matricellular Secreted protein acidic and rich in cysteine  (SPARC) in response to inflammatory cytokines.
4) Treg-derived SPARC is critically needed in intra-thrombic monocyte fibrinolysis and differentiation.
5) Acceleration of thrombolysis by selective Treg expansion is only effective in the resolution phase.

Conclusions: A specialized population of SPARC+ clot Treg is critically needed in clot resorption and can be therapeutically exploited through IL-2-mediated Treg expansion.

To cite this abstract in AMA style:

Shahneh F, Klein M, Frauhammer F, Probst HC, Schäfer K, K Raker V, Becker C. Specialized SPARC-forming Regulatory T Cells Control Venous Blood Clot Degradation [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 2). https://abstracts.isth.org/abstract/specialized-sparc-forming-regulatory-t-cells-control-venous-blood-clot-degradation/. Accessed May 19, 2022.

« Back to ISTH 2021 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/specialized-sparc-forming-regulatory-t-cells-control-venous-blood-clot-degradation/

Simple Search

Supported By:

Bristol Myers Squibb and Pfizer

ISTH 2021 Congress site

Visit the official web site for the ISTH 2021 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley